Qureshi Sajid S, Kembhavi Seema, Bhagat Monica, Laskar Siddharth, Chinnaswamy Girish, Vora Tushar, Prasad Maya, Ramadwar Mukta, Desai Saral, Khanna Nehal, Kurkure Purna, Shah Sneha, Shankdhar Vinay, Yadav Prabha
Division of Pediatric Surgical Oncology, Department of Surgical Oncology, Tata Memorial Centre, Mumbai, India.
J Surg Oncol. 2014 Nov;110(6):689-95. doi: 10.1002/jso.23698. Epub 2014 Jun 25.
The rarity of Ewing sarcoma (ES) of the jaw coupled with the technical challenge of resection and associated functional and cosmetic impairment has resulted in deficient data on surgical management of these tumors. The purpose of this study is to describe the results of surgical excision and reconstruction of primary non-metastatic ES of the mandible and maxilla in children.
Consecutive patients (mandible = 6, maxilla = 5) treated with surgery from August 2005 to January 2013 were selected. All patients received induction chemotherapy and were selected for surgical resection based on the presence of specific criteria for operability.
The median age was 11.5 years (range 5-16 years). Free fibular osteocutaneous flap was commonly used for reconstruction. There were no complications related to microvascular anastomosis or flap loss. Five patients had 100% tumor necrosis and did not receive radiotherapy. Teeth alignment, chewing, swallowing, and speech were normal in all and donor site morbidity occurred in one. The 5-year overall, event-free survival, and local control are 87.5%, 72.9%, and 90%, respectively.
In eligible patients, surgery with contemporary reconstruction results in optimal oncological and functional outcome. Surgery also has the added advantage of identifying patients who may not need radiotherapy.
颌骨尤因肉瘤(ES)罕见,加之切除手术存在技术挑战以及相关的功能和美容损害,导致关于这些肿瘤手术治疗的数据不足。本研究的目的是描述儿童下颌骨和上颌骨原发性非转移性ES手术切除及重建的结果。
选取2005年8月至2013年1月接受手术治疗的连续患者(下颌骨6例,上颌骨5例)。所有患者均接受诱导化疗,并根据特定的可手术标准入选手术切除。
中位年龄为11.5岁(范围5 - 16岁)。游离腓骨骨皮瓣常用于重建。未发生与微血管吻合或皮瓣丢失相关的并发症。5例患者肿瘤坏死率达100%,未接受放疗。所有患者牙齿排列、咀嚼、吞咽及言语功能均正常,仅1例出现供区并发症。5年总生存率、无事件生存率和局部控制率分别为87.5%、72.9%和90%。
对于符合条件的患者,采用现代重建技术的手术可获得最佳的肿瘤学和功能结局。手术还有助于识别可能无需放疗的患者。